CDC42 and osteoarthritis: With respect to the emerging evidence for a potential antagonism between ERK5 and CDC42 signaling, it is also worth mentioning that the genetic disruption of Cdc42, Cdc42 knockdown, or inhibition of CDC42 activity significantly improved neovascularization and bone loss in an experimental mouse model of osteoarthritis [96].